Related Experiment Video
Updated: Apr 27, 2026
04:59
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
12.6K
Delayed, transient, postsolar truncal pruritus: a report of two cases
K B Salako1, A A Anstey, R A Logan
1Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, UK.
Clinical and Experimental Dermatology
|July 3, 2014
Summary
Two rare cases of delayed, transient trunk itching after sun exposure were identified. This sun-induced pruritus differs from other conditions and requires further study for treatment and natural history.
Area of Science:
- Dermatology
- Clinical Medicine
- Pruritus Research
Background:
- Sun exposure can trigger various dermatological conditions.
- Pruritus, or itching, is a common symptom with diverse etiologies.
- Understanding sun-induced pruritus is crucial for patient management.
Observation:
- Two distinct cases of delayed and transient pruritus localized to the trunk following sun exposure are reported.
- The pruritus onset was delayed after sun exposure, distinguishing it from immediate reactions.
- The itching was transient, resolving spontaneously, and confined to the trunk.
Findings:
- These cases represent a rare clinical condition of sun-induced pruritus.
- The transient nature and trunk localization differentiate this condition from previously described pruritic syndromes like brachioradial pruritus.
- The findings expand the known spectrum of cutaneous reactions to solar radiation.
Implications:
- Rigorous sun protection measures showed initial efficacy in managing the pruritus.
- Further research is needed to determine the specific treatment protocols and the natural history of this condition.
- Recognition of this distinct presentation can aid in accurate diagnosis and patient counseling regarding sun-induced pruritus.
Related Concept Videos
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
353
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
353
01:30Drug Toxicity: Allergic Reactions
206
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
206
01:24Graves Disease II: Pathophysiology
20
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
20
01:28Graves' Disease I: Introduction
19
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
19